VeraChem’s newly developed CloudVM2 capability applied in early stage R&D efforts
VeraChem has developed a capability to run its protein-ligand binding free energy software package on the Amazon Web Services cloud environment. This CloudVM2 package enables calculation of protein-ligand binding affinities for hundreds of ligands per day, and was recently applied in early stage R&D efforts by Sarfez Pharmaceuticals Inc.
